National HealthCare Corporation (NHC) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
16.58
↑+27% vs avg
5yr avg: 13.08
30Y Low3.4·High16.5
P/FCF
↓
21.18
↓-14% vs avg
5yr avg: 24.52
30Y Low1.9·High57.5
P/B Ratio
↑
2.93
↑+97% vs avg
5yr avg: 1.49
30Y Low0.9·High10.4
ROE
↓
11.7%
↓+20% vs avg
5yr avg: 9.7%
30Y Low-14%·High44%
Debt/EBITDA
↓
0.46
↓-65% vs avg
5yr avg: 1.33
30Y Low0.1·High3.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
NHC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
National HealthCare Corporation trades at 26.3x earnings, 26% above its 5-year average of 20.8x, sitting at the 93rd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 19%. On a free-cash-flow basis, the stock trades at 21.2x P/FCF, 14% below the 5-year average of 24.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.1B | $2.1B | $1.7B | $1.4B | $919M | $1.0B | $1.0B | $1.3B | $1.2B | $927M | $1.2B |
| Enterprise Value | $3.1B | $2.1B | $1.8B | $1.4B | $986M | $1.1B | $1.1B | $1.5B | $1.1B | $856M | $1.3B |
| P/E Ratio → | 26.28 | 17.87 | 16.47 | 21.29 | 41.03 | 7.56 | 24.42 | 19.47 | 20.27 | 16.51 | 22.83 |
| P/S Ratio | 2.08 | 1.42 | 1.29 | 1.24 | 0.86 | 1.04 | 1.04 | 1.33 | 1.22 | 0.96 | 1.25 |
| P/B Ratio | 2.93 | 2.00 | 1.71 | 1.56 | 1.05 | 1.15 | 1.28 | 1.70 | 1.63 | 1.32 | 1.83 |
| P/FCF | 21.18 | 14.43 | 21.05 | 17.06 | — | 45.55 | 5.63 | 18.01 | 17.41 | 14.93 | 40.75 |
| P/OCF | 17.01 | 11.59 | 15.64 | 12.78 | 105.14 | 16.79 | 5.02 | 13.26 | 12.14 | 9.82 | 12.68 |
P/E links to full P/E history page with 30-year chart
NHC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
National HealthCare Corporation's enterprise value stands at 16.6x EBITDA, 27% above its 5-year average of 13.1x. The Healthcare sector median is 14.2x, placing the stock at a 17% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.40 | 1.40 | 1.23 | 0.92 | 1.09 | 1.09 | 1.51 | 1.11 | 0.89 | 1.38 |
| EV / EBITDA | 16.58 | 11.26 | 14.22 | 14.19 | 13.63 | 12.08 | 11.84 | 16.50 | 11.12 | 8.85 | 12.82 |
| EV / EBIT | 21.78 | 12.57 | 12.92 | 15.80 | 35.49 | 7.33 | 19.84 | 16.56 | 13.70 | 10.78 | 15.17 |
| EV / FCF | — | 14.27 | 22.79 | 16.89 | — | 48.12 | 5.89 | 20.48 | 15.87 | 13.78 | 45.13 |
NHC Profitability
Margins and return-on-capital ratios measuring operating efficiency
National HealthCare Corporation earns an operating margin of 9.5%. Operating margins have expanded from 5.0% to 9.5% over the past 3 years, signaling improving operational efficiency. ROE of 11.7% is modest. ROIC of 9.9% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.8% | 67.8% | 37.5% | 37.6% | 36.1% | 34.1% | 37.9% | 40.5% | 40.6% | 40.7% | 40.7% |
| Operating Margin | 9.5% | 9.5% | 6.6% | 5.0% | 3.0% | 5.0% | 4.9% | 4.9% | 5.7% | 5.6% | 6.6% |
| Net Profit Margin | 7.9% | 7.9% | 7.9% | 5.9% | 2.1% | 13.7% | 4.3% | 6.8% | 6.0% | 5.8% | 5.5% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 11.7% | 10.8% | 7.5% | 2.5% | 16.2% | 5.3% | 9.0% | 8.2% | 8.4% | 8.0% |
| ROA | 7.9% | 7.9% | 7.2% | 5.2% | 1.7% | 10.0% | 3.2% | 5.8% | 5.4% | 5.1% | 4.7% |
| ROIC | 9.9% | 9.9% | 6.4% | 4.7% | 2.5% | 4.2% | 4.0% | 4.6% | 6.7% | 5.9% | 6.1% |
| ROCE | 11.2% | 11.2% | 7.2% | 5.3% | 2.9% | 4.6% | 4.4% | 4.9% | 6.0% | 5.8% | 6.6% |
NHC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
National HealthCare Corporation carries a Debt/EBITDA ratio of 0.5x, which is very conservative (86% below the sector average of 3.2x). The company holds a net cash position — cash of $111M exceeds total debt of $87M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 26.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.08 | 0.22 | 0.10 | 0.14 | 0.18 | 0.24 | 0.30 | 0.11 | 0.18 | 0.24 |
| Debt / EBITDA | 0.46 | 0.46 | 1.68 | 0.94 | 1.74 | 1.82 | 2.15 | 2.54 | 0.80 | 1.31 | 1.51 |
| Net Debt / Equity | — | -0.02 | 0.14 | -0.02 | 0.08 | 0.06 | 0.06 | 0.23 | -0.14 | -0.10 | 0.20 |
| Net Debt / EBITDA | -0.13 | -0.13 | 1.09 | -0.14 | 0.93 | 0.64 | 0.52 | 1.99 | -1.08 | -0.74 | 1.24 |
| Debt / FCF | — | -0.16 | 1.74 | -0.16 | — | 2.57 | 0.26 | 2.47 | -1.54 | -1.15 | 4.38 |
| Interest Coverage | 26.50 | 26.50 | 33.99 | 274.88 | 49.37 | 178.56 | 38.47 | 29.07 | 16.94 | 16.25 | 21.35 |
Net cash position: cash ($111M) exceeds total debt ($87M)
NHC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.77x means National HealthCare Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.89x to 1.77x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | 1.77 | 1.81 | 1.89 | 1.79 | 1.62 | 1.62 | 1.75 | 2.04 | 2.12 | 1.93 |
| Quick Ratio | 1.77 | 1.77 | 1.77 | 1.86 | 1.75 | 1.59 | 1.59 | 1.71 | 1.99 | 2.08 | 1.88 |
| Cash Ratio | 1.22 | 1.22 | 0.92 | 1.04 | 0.92 | 0.97 | 1.15 | 1.04 | 1.16 | 1.28 | 1.26 |
| Asset Turnover | — | 0.99 | 0.85 | 0.87 | 0.84 | 0.72 | 0.72 | 0.77 | 0.91 | 0.88 | 0.85 |
| Inventory Turnover | — | — | 89.71 | 96.45 | 96.81 | 77.61 | 69.39 | 79.67 | 78.01 | 79.97 | 72.99 |
| Days Sales Outstanding | — | 33.59 | 38.20 | 34.87 | 34.07 | 34.87 | 33.37 | 33.45 | 36.70 | 35.47 | 31.91 |
NHC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
National HealthCare Corporation returns 1.7% to shareholders annually — split between a 1.2% dividend yield and 0.5% buyback yield. The payout ratio of 32.2% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.2% | 1.8% | 2.2% | 2.5% | 3.8% | 3.1% | 3.1% | 2.4% | 2.5% | 3.0% | 2.2% |
| Payout Ratio | 32.2% | 32.2% | 36.3% | 53.2% | 154.2% | 23.1% | 76.2% | 45.8% | 50.6% | 50.2% | 51.0% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.8% | 5.6% | 6.1% | 4.7% | 2.4% | 13.2% | 4.1% | 5.1% | 4.9% | 6.1% | 4.4% |
| FCF Yield | 4.7% | 6.9% | 4.8% | 5.9% | — | 2.2% | 17.8% | 5.6% | 5.7% | 6.7% | 2.5% |
| Buyback Yield | 0.5% | 0.7% | 0.8% | 0.2% | 1.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.0% | 0.7% |
| Total Shareholder Yield | 1.7% | 2.5% | 3.0% | 2.7% | 4.8% | 3.1% | 3.1% | 2.4% | 2.6% | 3.0% | 2.9% |
| Shares Outstanding | — | $16M | $16M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M |
Peer Comparison
Compare NHC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 NHCYou | $3B | 26.3 | 16.6 | 21.2 | 67.8% | 9.5% | 11.7% | 9.9% | 0.5 |
 EHC | $10B | 17.7 | 8.9 | 22.2 | 95.7% | 17.7% | 18.5% | 13.9% | 2.0 |
 PNTG | $1B | 39.8 | 26.7 | 44.2 | 12.9% | 5.4% | 8.6% | 5.6% | 7.6 |
 ADUS | $2B | 18.1 | 12.2 | 16.9 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
 CCRN | $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 |
 SEM | $2B | 14.0 | 12.1 | 5.4 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 |
 SGRY | $2B | -23.9 | 10.1 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 |
 CHE | $6B | 23.7 | 15.0 | 18.3 | 30.0% | 13.4% | 25.3% | 23.7% | 0.4 |
 HCSG | $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 ENSG | $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 MCK | $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
NHC — Frequently Asked Questions
Quick answers to the most common questions about buying NHC stock.
What is National HealthCare Corporation's P/E ratio?
National HealthCare Corporation's current P/E ratio is 26.3x. The historical average is 21.5x. This places it at the 93th percentile of its historical range.
What is National HealthCare Corporation's EV/EBITDA?
National HealthCare Corporation's current EV/EBITDA is 16.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.0x.
What is National HealthCare Corporation's ROE?
National HealthCare Corporation's return on equity (ROE) is 11.7%. The historical average is 11.6%.
Is NHC stock overvalued?
Based on historical data, National HealthCare Corporation is trading at a P/E of 26.3x. This is at the 93th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is National HealthCare Corporation's dividend yield?
National HealthCare Corporation's current dividend yield is 1.23% with a payout ratio of 32.2%.
What are National HealthCare Corporation's profit margins?
National HealthCare Corporation has 67.8% gross margin and 9.5% operating margin.
How much debt does National HealthCare Corporation have?
National HealthCare Corporation's Debt/EBITDA ratio is 0.5x, indicating low leverage. A ratio below 2x is generally considered financially healthy.